AR010875A1 - Tableta para liberacion controlada de agentes activos. - Google Patents

Tableta para liberacion controlada de agentes activos.

Info

Publication number
AR010875A1
AR010875A1 ARP980100120A ARP980100120A AR010875A1 AR 010875 A1 AR010875 A1 AR 010875A1 AR P980100120 A ARP980100120 A AR P980100120A AR P980100120 A ARP980100120 A AR P980100120A AR 010875 A1 AR010875 A1 AR 010875A1
Authority
AR
Argentina
Prior art keywords
tablet
active agent
polymeric material
aqueous medium
controlled release
Prior art date
Application number
ARP980100120A
Other languages
English (en)
Spanish (es)
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of AR010875A1 publication Critical patent/AR010875A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ARP980100120A 1997-01-10 1998-01-09 Tableta para liberacion controlada de agentes activos. AR010875A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US78176197A 1997-01-10 1997-01-10

Publications (1)

Publication Number Publication Date
AR010875A1 true AR010875A1 (es) 2000-07-12

Family

ID=25123834

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980100120A AR010875A1 (es) 1997-01-10 1998-01-09 Tableta para liberacion controlada de agentes activos.

Country Status (8)

Country Link
US (1) US6033685A (enExample)
EP (1) EP0951279A1 (enExample)
JP (1) JP5170723B2 (enExample)
AR (1) AR010875A1 (enExample)
AU (1) AU5609998A (enExample)
CA (1) CA2277220A1 (enExample)
WO (1) WO1998030208A1 (enExample)
ZA (1) ZA9880B (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1011045A3 (fr) * 1997-03-14 1999-04-06 Ucb Sa Compositions pharmaceutiques pour la liberation controlee de substances actives.
FR2772615B1 (fr) * 1997-12-23 2002-06-14 Lipha Comprime multicouche pour la liberation instantanee puis prolongee de substances actives
GB9901688D0 (en) * 1999-01-26 1999-03-17 Unilever Plc Detergent compositions
AR030557A1 (es) 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento
US6960357B2 (en) * 2001-05-25 2005-11-01 Mistral Pharma Inc. Chemical delivery device
US7052706B2 (en) * 2001-06-08 2006-05-30 Nostrum Pharmaceuticals, Inc. Control release formulation containing a hydrophobic material as the sustained release agent
US20030104052A1 (en) * 2001-10-25 2003-06-05 Bret Berner Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
US20030152622A1 (en) * 2001-10-25 2003-08-14 Jenny Louie-Helm Formulation of an erodible, gastric retentive oral diuretic
CA2409552A1 (en) * 2001-10-25 2003-04-25 Depomed, Inc. Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
US20030091630A1 (en) * 2001-10-25 2003-05-15 Jenny Louie-Helm Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
US20030133982A1 (en) * 2001-12-20 2003-07-17 Heimlich John M. Zero-order sustained release dosage forms and method of making same
PL223471B1 (pl) * 2002-03-15 2016-10-31 Cypress Bioscience Inc Kompozycja farmaceutyczna zawierająca milnacypran do stosowania w leczeniu zespołu nadwrażliwości jelita grubego
US20060003004A1 (en) * 2002-10-25 2006-01-05 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
US20040132826A1 (en) * 2002-10-25 2004-07-08 Collegium Pharmaceutical, Inc. Modified release compositions of milnacipran
AU2003288041A1 (en) * 2002-12-06 2004-06-30 Ucb Farchim, S.A. Tablet comprising efletirizine and pseudoephedrine
US20040228830A1 (en) * 2003-01-28 2004-11-18 Collegium Pharmaceutical, Inc. Multiparticulate compositions of milnacipran for oral administration
JP2006514672A (ja) * 2003-03-04 2006-05-11 ノストラム・ファーマスーティカルズ・インコーポレイテッド 疎水性物質を徐放剤として含有する制御性放出製剤
DK1575565T3 (da) * 2003-08-08 2010-04-12 Biovail Lab Int Srl Tablet med modificeret frigivelse af bupropion-hydrochlorid
CA2552064A1 (en) * 2003-12-31 2005-07-21 Actavis Group Hf Atomoxetine formulations
KR20070043806A (ko) * 2004-07-29 2007-04-25 사노피-아벤티스 ｐＨ에 매우 의존적인 용해도를 가지는 활성 성분의 제어방출을 위한 약제학적 다층 정제
EP1942875B1 (en) * 2005-08-24 2015-08-12 Rubicon Research Private Limited Controlled release formulation
US8691272B2 (en) * 2005-12-30 2014-04-08 Intelgenx Corp. Multilayer tablet
JP4953673B2 (ja) * 2006-03-22 2012-06-13 リンテック株式会社 経口投与剤
US20080107725A1 (en) * 2006-10-13 2008-05-08 Albano Antonio A Pharmaceutical Solid Dosage Forms Comprising Amorphous Compounds Micro-Embedded in Ionic Water-Insoluble Polymers
KR100885029B1 (ko) 2007-02-07 2009-02-23 지엘팜텍 주식회사 경구투여용 서방성 삼중정제
EP2242485A4 (en) * 2008-02-15 2013-05-08 Sun Pharma Advanced Res Co Ltd ORAL TABLET WITH CONTROLLED RELEASE
US20100260842A1 (en) * 2009-04-06 2010-10-14 Rashmi Nair Pseudoephedrine pharmaceutical formulations
EP2461801A2 (en) * 2009-08-05 2012-06-13 Lupin Limited Controlled release pharmaceutical compositions of milnacipran
US9572909B2 (en) * 2009-09-14 2017-02-21 Virginia Commonwealth University Electrospun nerve guides for nerve regeneration designed to modulate nerve architecture
US10610528B2 (en) 2009-12-08 2020-04-07 Intelgenx Corp. Solid oral film dosage forms and methods for making same
US20110136815A1 (en) 2009-12-08 2011-06-09 Horst Zerbe Solid oral film dosage forms and methods for making same
US10485770B2 (en) 2009-12-21 2019-11-26 Aptapharma, Inc. Functionally-coated multilayer tablets
SG174658A1 (en) 2010-04-01 2011-10-28 Theravida Inc Pharmaceutical formulations for the treatment of overactive bladder
RU2718906C2 (ru) 2016-01-20 2020-04-15 Теравида, Инк. Способы и композиции для лечения гипергидроза

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE564759A (enExample) * 1955-12-22
JPS5839618A (ja) * 1981-09-04 1983-03-08 Chugai Pharmaceut Co Ltd 持続性積層錠剤
US4756911A (en) * 1986-04-16 1988-07-12 E. R. Squibb & Sons, Inc. Controlled release formulation
US5114719A (en) * 1987-04-29 1992-05-19 Sabel Bernhard A Extended drug delivery of small, water-soluble molecules
EP0317780B1 (en) * 1987-11-25 1992-05-20 American Cyanamid Company Sustained (controlled) release delivery system for substituted dihydropyridine calcium channel blockers
JPH04360826A (ja) * 1991-06-07 1992-12-14 Bayer Yakuhin Kk 放出制御製剤
FR2677886B1 (fr) * 1991-06-18 1995-03-31 Adir Comprime matriciel permettant la liberation prolongee d'indapamide apres administration par voie orale.
ATE183642T1 (de) * 1991-10-04 1999-09-15 Yoshitomi Pharmaceutical Tablette mit verzögerter freisetzung
JPH0791500B2 (ja) * 1991-10-25 1995-10-04 太田インキ製造株式会社 印刷インキ組成物
IT1256393B (it) * 1992-11-17 1995-12-04 Inverni Della Beffa Spa Forme matriciali multistrato per il rilascio controllato di principi attivi
IT1265240B1 (it) * 1993-11-30 1996-10-31 Ekita Investments Nv Compressa farmaceutica a rilascio controllato, di forma lenticolare
CA2136810A1 (en) * 1994-06-30 1995-12-31 Franklin M. C. Chen Absorbent structure including an adhesive

Also Published As

Publication number Publication date
AU5609998A (en) 1998-08-03
WO1998030208A1 (en) 1998-07-16
US6033685A (en) 2000-03-07
CA2277220A1 (en) 1998-07-16
ZA9880B (en) 1998-07-08
JP2001508440A (ja) 2001-06-26
EP0951279A1 (en) 1999-10-27
JP5170723B2 (ja) 2013-03-27

Similar Documents

Publication Publication Date Title
AR010875A1 (es) Tableta para liberacion controlada de agentes activos.
IT1265240B1 (it) Compressa farmaceutica a rilascio controllato, di forma lenticolare
ES2112946T3 (es) Sistemas de matriz multicapa para la liberacion controlada de principios activos.
DK1183014T3 (da) Smagsmaskerede orale farmaceutiske sammensætninger med kontrolleret frigivelse
ES2036457A1 (es) Forma de dosificacion farmaceutica solida oral de liberacion programada y procedimiento de preparacion.
ES2195979T3 (es) Microcapsulas de nucleo particulado con una capa de revestimiento laminar estable y procedimiento para su preparacion.
ES2103133T3 (es) Reservorio impregnable con una solucion de principio activo, para dispositivo ionoforetico de administracion transdermica de medicamentos, y procedimiento de fabricacion de dicho reservorio.
ES2120430T3 (es) Pastillas o comprimidos que contienen material genetico y portador inerte para los mismos y metodo para su preparacion.
MX9300998A (es) Sistema mejorado de liberacion farmaceutica y metodo para su preparacion.
DE69627835D1 (de) Feste pharmazeutische zusammensetzung aus nanopartikeln
MX9207263A (es) Sistema para el suministro de una substancia activa para la liberacion sostenida.
ES2135443T3 (es) Vehiculo mejorado para la administracion oral de omeprazol.
ES2052016T3 (es) Composicion emulsionada.
FR2798078B1 (fr) Organogel, comprenant un compose hydrophile sensible a l'oxydation et ses utilisations notamment cosmetiques
FR2800277B1 (fr) Compositions pharmaceutiques comprenant une substance active difficilement soluble et un milieu vehiculeur
ES2031491T3 (es) Tableta para uso farmaceutico capaz de liberar sustancias activas en momentos sucesivos.
FR2784583B1 (fr) Composition pharmaceutique a residence gastrique et a liberation controlee
AR026191A1 (es) Microperlas de hidrogel que tienen una capa secundaria
AR014753A1 (es) Formulacion farmaceutica que contiene un 2-[[(2-piridinil)metil]sulfinil] bencimidazol que tiene una actividad antiulcerosa, y un proceso para lapreparacion de dicha formulacion
IS2866B (is) Magavarin ómeprasólörkorn, aðferð til að fá slík og lyfjaefnablöndur
DK1077680T3 (da) Fremgangsmåde til fremstilling af en med bånd forsynet aktivt-stof-doseringsform til prolongeret release
SE0004671D0 (sv) Pharmaceutical formulation
SE9704401D0 (sv) Matrix pellets for greasy, oily or sticky drug substances
AR043070A1 (es) Sistema monolitico que contiene una o mas drogas, formado por tres capas con diferentes mecanismos de liberacion
CO5011082A1 (es) Formulacion medicamentosa con liberacion controlada de sus- tancia activa

Legal Events

Date Code Title Description
FB Suspension of granting procedure